About
0.02CAD+0.00 +0.00%
Live at 08:49 GMT+00:00Market Cap$1.84M
Volume3.0K
Beta-0.84
RSI48.73
Neural Therapeutics Inc. — investor relations, events, news, and company updates on 6ix.
Latest News
May 1 2026
Neural Therapeutics Announces Filing and Mailing of Meeting Materials for Annual and Special Meeting to Approve Series B Transactions with CWE
Mar 27 2026
Neural Therapeutics Announces Amendment to SIO Agreement, Concurrent Financing Terms, Shareholder Meeting Date and RSU Grant
Feb 19 2026
Neural Therapeutics Announces CSE Application to Acquire Full Ownership of Hanf.com, Shareholder Meeting, SIO Agreement Amendment and Concurrent Financing
Feb 10 2026
Neural Portfolio Company Hanf.com Reports Strong Fiscal 2025 Results with 58% Revenue Growth and Positive Normalized Operating Income
Jan 27 2026
Neural's Portfolio Company Hanf.com Announces Sales Start of Ritual Herbs Nicotine and Tobacco Free Products
Recent Videos

Neural Therapeutics CEO Ian Campbell discusses potential CSE listing and future plans
May 16, 2024

How can psychedelic treatments be rolled out at scale if therapy is required? - Neural Therapeutics
Dec 20, 2023

What side effects should we be concerned about from psychedelic treatments? - Neural Therapeutics
Dec 20, 2023

What are the long-term effects of psychedelics on bodily health? - Neural Therapeutics
Dec 19, 2023
Community Chat
Ask AI
Try asking
Translate